Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003)
Authors:
Open Access
- 1 December 2005
- journal article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 11 (12) , 974-984
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Activities of Doripenem (S-4661) against Drug-Resistant Clinical PathogensAntimicrobial Agents and Chemotherapy, 2004
- Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluationsJournal of Antimicrobial Chemotherapy, 2004
- In Vitro Antimicrobial Activity of Doripenem, a New CarbapenemAntimicrobial Agents and Chemotherapy, 2004
- Properties and potential of ertapenemJournal of Antimicrobial Chemotherapy, 2003
- Recent developments in carbapenemsExpert Opinion on Investigational Drugs, 2002
- Comparative in vitro Activity of S-4661, a New Parenteral Carbapenem, and Other Antimicrobial Agents against Respiratory PathogensChemotherapy, 2000
- In Vitro and In Vivo Antibacterial Activities of S-4661, a New CarbapenemAntimicrobial Agents and Chemotherapy, 1998
- Comparative stability of carbapenem and penem antibioties to human recombinant dehydro-peptidase-IJournal of Antimicrobial Chemotherapy, 1996
- Synthesis and Modification of a Novel 1.BETA.-Methyl Carbapenem Antibiotic, S-4661.The Journal of Antibiotics, 1996
- A Novel 1.BETA.-Methylcarbapenem Antibiotic, S-4661.Synthesis and Structure-activity Relationships of 2-(5-Substituted Pyrrolidin-3-ylthio)-1.BETA.-methylcarbapenems.The Journal of Antibiotics, 1996